{"entity":{"id":"3e67a458-5786-5de8-9e1e-7c0d2217bb7e","name":"FRATES JAMES M","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001235598","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"officer","share":null,"asset":{"id":"9406e386-c399-56ce-9f78-0b28d2649efb","name":"Amylyx Pharmaceuticals, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"e1a91a56-0391-5d6e-9f93-0da42f8dd395","name":"Sage Therapeutics, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001235598"}],"source":"corpus"}